Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Medicinal Product Name Xeomin(R), Atc M03Ax21

AOK Bayern - Die Gesundheitskasse Germany has Released a tender for Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Medicinal Product Name Xeomin(R), Atc M03Ax21 in Pharmaceuticals. The tender was released on Jan 17, 2025.

Country - Germany

Summary - Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Medicinal Product Name Xeomin(R), Atc M03Ax21

Deadline - Jan 05, 2027

GT reference number - 101699578

Product classification - Pharmaceutical products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 101699578

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: This is not an open procedure, but a so-called open-house model! The form for the open procedure is only used because there is no form for the open-house model. Contracts concluded in the open-house model are not subject to procurement l aw due to the lack of a selection decision. The use of this form does not entail submission to procurement law regulations. AOK Bayern intends to conclude non-exclusive discount agreements with all interested pharmaceutical companies for the active ingredient botulinum toxin type A, finished medicinal product name Xeomin(R), ATC M03AX21, in accordance with Section 130a Paragraph 8 of the Social Code Book V. AOK Bayern offers all interested pharma

Gt Ref Id - 101699578

Deadline - Jan 05, 2027

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database